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Abstract
Background: Three-dimensional in vitro culture of cancer cells are used to predict the effects of
prospective anti-cancer drugs in vivo. In this study, we present an automated image analysis protocol
for detailed morphological protein marker profiling of tumoroid cross section images.
Methods: Histologic cross sections of breast tumoroids developed in co-culture suspensions of
breast cancer cell lines, stained for E-cadherin and progesterone receptor, were digitized and pixels
in these images were classified into five categories using k-means clustering. Automated
segmentation was used to identify image regions composed of cells expressing a given biomarker.
Synthesized images were created to check the accuracy of the image processing system.
Results: Accuracy of automated segmentation was over 95% in identifying regions of interest in
synthesized images. Image analysis of adjacent histology slides stained, respectively, for Ecad and
PR, accurately predicted regions of different cell phenotypes. Image analysis of tumoroid cross
sections from different tumoroids obtained under the same co-culture conditions indicated the
variation of cellular composition from one tumoroid to another. Variations in the compositions of
cross sections obtained from the same tumoroid were established by parallel analysis of Ecad and
PR-stained cross section images.
Conclusion: Proposed image analysis methods offer standardized high throughput profiling of
molecular anatomy of tumoroids based on both membrane and nuclei markers that is suitable to
rapid large scale investigations of anti-cancer compounds for drug development.
Background
Fast, repeatable, and reliable methods are needed for eval-
uating the efficacy of prospective drugs in cancer research.
Cell lines derived from cancer tissues are used extensively
to model in vivo drug response as they can be transferred,
reproduced, and analyzed in standardized assays [1,2].
Effects of therapeutic compounds have been studied
widely on cell lines isolated from breast, skin, colon, pros-
tate, lung, brain, and the bone marrow [3-9]. A compre-
hensive database of several human cancer cell lines'
chemosensitivity to select anticancer drugs is presented by
Dan et al[10]. The limitations of two-dimensional assays
of cancer cell cultures in representing in vivo tissue condi-
tions may be due to the lack of cell to cell and cell to extra-
cellular matrix interactions [11]. Three dimensional cell
cultures promote cell to cell interaction in a more realistic
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with one another as well as with the extracellular matrix
that they produce [13]. While the tumoroids grown in
vitro lack the actual tissue micro environment known to
affect the tumorigenic properties of cell lines [11,12,14],
the high cost and low repeatability of in vivo tumor mod-
els in immune deficient host systems prevent standard-
ized large scale and high throughput analyses. Therefore,
in vitro tumoroids developed using cancer cell lines
remain the primary models for standardized high
throughput studies of cancer [15].
The potential benefits of automated image cytology are
widely recognized for rapid and standardized assessment
of biomarker status [16]. Comparisons of manual and
automated methods in assessing biomarker expression
showed a high correlation, establishing automated image
analysis methods as effective and reliable alternatives to
painstaking manual microscopic examinations [17,18].
Computational image analysis algorithms proposed in
the literature for quantitative evaluation of histological
tissue cross sections can be grouped under two categories
based on the scale at which they characterize tissue anat-
omy [19,20]. The first group focuses on the appearance of
cell nuclei [21-25], while the second group studies the
appearance of cell clusters in terms of the spatial arrange-
ment of cell nuclei as well as the texture characteristics of
the tissue [26-29]. The expressions of nuclei-bound
biomarkers were analyzed by detecting the nuclei in digi-
tized histological cross-section images, and then classify-
ing the positively- and negatively-stained nuclei within
the field of view [30-33]. Lacking the well-defined spatial
locus of the nucleus, membrane-bound biomarkers were
assessed through densitometric analysis across larger tis-
sue structures [34,35]. A fractal-based texture analysis
method was proposed to identify positively and nega-
tively stained tissue distributions in histology slides [36].
A software platform capable of combining different com-
putational modules for processing histology images has
been developed to enable designing custom image analy-
sis pipelines with separate detection layers for nuclei and
cell membranes in high-resolution histology images [37].
Open access systems operated by internet web servers,
such as EAMUS™, have recently been developed for
extracting quantitative parameters from immunohisto-
chemically stained tissue slides [38,39] and tissue micro-
arrays [40]. Several commercial software packages have
also been developed for cytometric analysis of histological
slides and tissue microarrays such as the Tissue Microarray
Analysis Software (TMAx) by Beecher Instruments
(Beecher Instruments, Inc., 686 Progress Way, Sun Prairie,
WI 53590, USA), the Extended Slide Wizard by Tripath
Imaging (Tripath Imaging, Inc., 780 Plantation Drive,
Burlington, NC 27215, USA), the Discovery Image Ana-
lyser by Becton-Dickinson (Becton-Dickinson Bio-
sciences, Postbus 757, 2400 AT Alphen aan den Rijn, The
Netherlands), the TissueQuest software by TissueGnostics
(TissueGnostics GmbH, Taborstraße 10/2/8, 1020
Vienna, Austria FN 234341 w) and the Automated Cellu-
lar Imaging System (ACIS) by Clarient (Clarient, Inc., 31
Columbia, Aliso Viejo, CA 92656, USA), along with the
Stanford Tissue Microarray Analysis Software: CaseX-
plorer [41]. Among these, ACIS in particular has been
used extensively, in the analysis of immunohistochemi-
cally stained lung cancer specimens for p53, ki-67, and
p120 status [42] as well as HER-2/neu expression in breast
cancer by both immunohistochemical staining and fluo-
rescence in-situ hybridization [43-45]. However, a com-
prehensive methodology for automated analysis of
histological sections of heterogeneous tumoroids stained
for a variety of molecular markers, from construction of
whole cross section images using overlapping snapshots
to molecular profiling of DNA spots, has not been formal-
ized. The differences in the microenvironment of the
tumoroids to that of the actual tissue results in differences
in the cross section images of tumoroids, and the compu-
tational algorithms used in studying histology slides
obtained from surgically resected or biopsied specimens
have not been validated on tumoroid cross section
images. A typical example to these differences is a drasti-
cally increased number of overlapping nuclei due to much
larger nuclear area [46].
We have studied the anatomy of co-cultures of poorly
invasive and highly invasive breast cancer cell lines using
digitized cross section images immunohistochemically
stained for E-cadherin (Ecad) and progesterone receptor
(PR) by automated image analysis methods. Positively
and negatively stained regions of cross section images
were delineated using image segmentation algorithms
based on pixel color. The DNA spots were identified in
positively and negatively stained image regions. Our
results showed that the Ecad+/PR+ and Ecad-/PR- cell
lines exhibited strong homophilic binding. This prefer-
ence was more pronounced in invasive cells which pro-
duced several Ecad/PR deficient tumoroids. All image
analysis algorithms were validated on synthetic images for
segmentation accuracy and DNA spot profiling perform-
ance. These results indicated that the tumoroids devel-
oped using mixture cell suspensions were anatomically
heterogeneous, and the automated image analysis meth-
ods developed in this study enabled rapid and accurate
morphological phenotyping of such tumoroids using
immunohistochemical staining for both membrane and
nuclear targets.Page 2 of 14
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Image Data
The image data used in this study were obtained by digi-
tizing histological cross sections of composite breast
tumoroids described in our previous publication [47].
Drexel University Institutional Review Board reviewed our
research involving the histology slides of in vitro tumor-
oids composed of cultured cancer cells and determined
that it was in compliance with Drexel university research
policy involving biological samples. Briefly, cultured
human breast cancer cells of highly invasive
(MDAMB231) and poorly invasive (MCF7, and ZR751)
phenotypes were co-cultured at respective concentrations
of 25% and 75% in a rotating wall vessel bioreactor to
form a large number of tumoroids. These large cell aggre-
gates were harvested after 8 days of culture in a rotating
wall vessel (RWV) bioreactor (10 mL disposable High
Aspect Ratio Vessel, HARV, Synthecon Inc., Houston TX).
Poorly invasive cell lines used in co-culture were estrogen
receptor (ER), progesterone receptor (PR), and E-cadherin
(Ecad) positive [48-51] whereas the highly invasive
MDAMB231 breast cancer cells were ER, PR and Ecad neg-
ative [52]. Tumoroids were processed for routine histol-
ogy and immunohistochemistryby fixation in 10%
neutral buffered formalin (Formalde-Fresh, Fisher), dehy-
drated by a series of alcohol baths and embedded in par-
affin. Embedded tumoroids were sectioned at 10 µm
intervals. Serial sections were prepared and were stained
with hematoxylin and eosin to identify RNS regions in
blue. In addition, ten of these slides were PAP-stainedfor
Ecad (mouse anti-E-cadherin, clone 4A2C7, Zymed Labo-
ratories Inc., 561 Eccles Avenue, South San Francisco, CA,
94080) and ten others for PR (DAKO monoclonal mouse
anti-human progesterone receptor, clone PgR 636, DAKO
Corporation, 6392 Via Real, Carpinteria, CA, 93013).
Ecad-staining exemplified membrane-targeting biomark-
ers, and PR-staining exemplified nuclei/cytoplasm-target-
ing biomarkers.
Digitized images of histology sections of breast tumoroids
obtained under co-culture conditions were collected at
H40 magnification scale using Coolscope VS Digital
Microscope (Nikon, Kanagawa, Japan) and the dedicated
Coolscope VS Suite (Bacus, IL) imaging software. Image
collection involved consecutive overlapping snapshots at
a color depth of 24 bits using the graphical user interface
of the Coolscope VS Suite. These snapshots were later
merged in software to produce a single image containing
individual tumoroid cross sections. The pixel sizes of the
resulting images were 0.17 µm H 0.17 µm (Figure 1).
Prior to processing, the color compositions of all image
pixels were converted from the native RGB representation
to the CIEL*a*b* representation [53]. The CIEL*a*b*
color space is characterized by the luminance L* along
with the chromaticity indices a* and b*. The details of this
color conversion are provided in the Appendix. One
advantage of using the CIEL*a*b* color representation
instead of the RGB representation native to the image
acquisition system is the linearization of the color differ-
ences: The CIEL*a*b* color space is designed to capture
the nonlinear perception of the human visual system, so
that the Euclidean distances between colors in the
CIEL*a*b* space mimic closely the differences perceived
by an average human eye [53]. The CIEL*a*b* space pro-
vides a device independent color representation by factor-
ing in the white point of the image acquisition device.
This enables standardized processing of images obtained
using different imaging systems.
Segmentation of cell clusters based on membrane 
targeting biomarkers
Pixel classes in Ecad-stained tumoroid cross section
images were determined using k-means unsupervised
clustering on a reference image [54]. The reference image
was selected to exhibit all the regions of interest for stud-
ying the tumoroid cross-section images in our dataset in
abundance, and therefore, to present the most complete
and statistically accurate description of the data for train-
ing the classifiers. The segmentations achieved on the ref-
erence image for k = 2, 3, 4, 5, and 6 classes were evaluated
visually for their ability to distinguish different tumoroid
cross section image constituents. The segmentation
obtained using k = 5 delineated the following pixel classes
presented in the order of light to dark: E1: bright pixels in
regions void of tissues and cells; E2: pixels that belonged
to cell cytoplasm; E3: pixels that belonged to chromatin
rich regions such as the cross sections of cell nuclei; E4:
pixels that belong to cell cytoplasm stained by diffusing
Ecad staining on the cell membrane; and E5: the pixels
that were on the membranes of the Ecad+ cells and their
immediate vicinity. The cluster centers determined by the
5-class k-means clustering for the reference image were
used in the segmentation by nearest neighbor classifica-
tion of the images of Ecad-stained histology slides used in
this study. Note that this algorithm was designed to iden-
tify pixel clusters that exhibited statistically conspicuous
color separation, and not to quantify the actual intensity
of staining.
Classification of pixels in images decorated by protein
markers for Ecad into five categories was a first step in the
automated delineation of the regions of the histology
images composed of cells expressing the protein marker.
In Ecad-stained cross section images, these regions typi-
cally contained pixels from four of the five categories
described above (E2 to E5). Image regions that consisted
of Ecad expressing cells were determined via automated
classification of individual image pixels into belonging to
either Ecad expressing or Ecad negative categories byPage 3 of 14
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Image processing pipeline used to analyze immunohistochemically stained tumoroid cross section imagesFigure 1
Image processing pipeline used to analyze immunohistochemically stained tumoroid cross section images. After the tumoroid 
cross sections were digitized at 40 ×, different tissue components were identified using unsupervised clustering and classifica-
tion. Using the spatial distribution of pixels associated with positively and negatively stained cells, the staining patterns were 
identified. At the same time, the spatial distributions of DNA-rich pixels were analyzed and individual DNA spots were identi-
fied.
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and E5 classes in the immediate neighborhood of the
pixel. The size of this neighborhood was determined by
the standard Gaussian smoothing with standard deviation
τ = 6.30 µm. This region covers the diameters of two typi-
cal cells within an interval ± 2τ in order to obtain congru-
ent region delineations. The optimal threshold separating
image regions containing Ecad positive and Ecad negative
cells was determined by carrying out a k-means unsuper-
vised clustering (k = 2) on the set of ratios from the refer-
ence image after the set of staining ratios have been
normalized to optimally span the unit interval. The
threshold on the staining ratios was determined to be
0.1875, and was used to determine the positively stained
regions in all Ecad-stained tumoroid cross section images.
Segmentation of cell clusters based on nuclei/cytoplasm 
targeting biomarkers
Classification of the pixels in PR-stained tumoroid cross
section images followed the same strategy as above. First
pixel classes in a PR-stained reference image were deter-
mined via k-means clustering for k = 2, 3, 4, 5, and 6. The
segmentation with 5 classes was determined visually to
best capture the pixel types present in the cross section
image. The pixels in PR decorated images were classified
into the following categories: P1: pixels that belonged to
tissue void regions; P2: pixels that fell on the cytoplasm of
PR negative cells, P3: pixels that fell on the cytoplasm of
PR positive cells; P4: pixels that corresponded to the chro-
matin containing regions in PR negative cells; and P5: pix-
els that belonged to chromatin-rich regions in PR positive
cells. The cluster centers of these five classes were deter-
mined by the k-means unsupervised clustering. Then, the
images of the PR-stained tumoroid cross sections used in
the study were segmented by nearest neighbor classifica-
tion using these cluster centers obtained for the reference
dataset.
The positively stained regions in PR-stained tumoroid
cross section images were determined using a similar
method as for Ecad-stained cross section images. An opti-
mal threshold of 0.185 was determined by k-means unsu-
pervised clustering with k = 2 on the positive staining
ratios from the reference PR-stained tumoroid cross sec-
tion image after normalization (classes P3 and P5). This
threshold was later used to identify the positively stained
regions in all the remaining PR-stained cross section
images.
Accuracy of segmentation: testing with synthetic images
In order to elucidate the operating characteristics of the
image analysis algorithms used in the manuscript in a
controlled setting, we have carried out validation experi-
ments using synthesized Ecad and PR stained cross section
images. First, we have randomly generated a three dimen-
sional tissue block in a 128 µm × 128 µm × 64 µm vol-
ume. To this end, we have randomly placed a total of 489
seeds for individual cells, and partitioned the volume
among these seeds using a nearest neighbor rule. This
number corresponds to the number of idealized 16 µm-
wide spherical cells required to fill this volume. We have
then eliminated the cells that reside at the 4 sides of the
tissue block, and randomly placed ellipsoid nuclei inside
the remaining cells. A total of 9 horizontal cross sections
were obtained from this tissue block at 4 µm intervals
around the midsection, and the membranes, cytoplasms,
and the nuclei of positively and negatively stained cells
were marked. The staining status of each cell was also
assigned randomly.
Ecad and PR stained cross section images were generated
by randomly assigning colors to tissue map pixels from
among those observed in the reference tumoroid cross
section images in the corresponding pixel classes. The
color images were also smoothened in order to emulate
the effects of the point spread function of image acquisi-
tion. A total of 45 synthetic Ecad and Pr stained image
pairs were generated from 5 independently synthesized
tissue blocks, and the performances of the computational
methods were assessed in terms of tissue segmentation as
well as molecular and morphological profiling of DNA
spots.
Accuracy of segmentation using adjacent histology slides 
decorated with membrane-targeting and nuclei-targeting 
biomarkers
Segmentation accuracy on actual images was assessed
using the staining patterns obtained for adjacent histology
slides that were stained for Ecad and PR. Since the cells in
the composite tumoroids were either Ecad+ and PR+ or
Ecad- and PR-, the agreement between the staining pat-
terns in Ecad-stained and PR-stained cross section images
provided additional validation for the tissue segmenta-
tion algorithms.
Two measures of aerial concentrations of cell phenotypes
in a given tumoroid cross section image were used. The
first measure was obtained by the percentage of positively
and negatively stained regions across the whole cross sec-
tion image. In addition, the detected DNA spots were clas-
sified as positively-stained or negatively stained based on
the whether their centers of mass were in positively or neg-
atively stained regions. The percentage of positively and
negatively stained DNA spots provided the second meas-
ure of cell phenotype concentration in tumoroid cross sec-
tion images. These two measures of cell concentration
were then compared and contrasted between Ecad-stained
and PR-stained cross section images.Page 5 of 14
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synthetic images
The DNA-rich pixels in Ecad-stained tumoroid cross sec-
tion images are identified by image segmentation as the
E3 class and those in PR-stained cross section images are
identified as P4 and P5 classes. The indicator functions of
these classes across respective images define the binary
maps of DNA-rich pixels. First, we have refined these ini-
tial DNA-rich pixel maps by subsequent opening and clos-
ing operations of mathematical morphology using
circular structuring elements of radii 0.85 µm and 0.52
µm respectively. This process eliminated singleton DNA-
rich pixels and enhanced the spatial definitions of the
DNA spots. The remaining DNA blobs were further ana-
lyzed using a watershed transform and individual DNA
spots were identified [55]. This procedure identified all
spots of DNA-associated pixels regardless of whether they
belong to nucleus or mitochondria. A k-means unsuper-
vised clustering with k = 2 was used to determine the opti-
mal area threshold that separates the small DNA spots
that are most likely to be associated with mitochondria
than nuclei. DNA spots identified in Ecad-stained tumor-
oid cross section images were deemed to be nuclei cross
sections if their area A was greater than 41.56 µm2. In PR-
stained cross section images the threshold value for the
DNA spot area A was 36.2 µm2.
We have identified a series of morphological parameters
to characterize the shapes of the DNA spots identified in
the tumoroid cross section images. These parameters
included the cross sectional area of a DNA spot (A) and
the eccentricity ratio defined as  where α and β
denote the major and minor axis of the best fitting ellip-
soid to the DNA spot. In addition, we have computed the
mean inter-spot distance (D) for each DNA spot by taking
the average of the Euclidean distances from its center of
mass to those of the nearest 10 DNA spots. We have also
determined whether each identified DNA spot resides in a
positively stained region or a negatively stained region of
a tumoroid cross section image based on the location of
its center of mass and the previously obtained cross sec-
tional staining patterns. Note that since the cross sectional
areas of the retained DNA spots were much larger than the
structural elements used for morphological filtering, the
subsequent effects on the shape parameters were insignif-
icant.
We have assessed the accuracy of the DNA spot detection
and morphological profiling algorithms on the synthetic
images generated previously. Specifically, we have used
these algorithms to identify the DNA spots in the syn-
thetic images and measure their morphological parame-
ters. We have then computed the DNA spot detection rates
and the error statistics on morphological parameters by
comparing the measured spot areas, eccentricities, and
average inter-spot distances to the actual values averaged
over 10 synthetic images.
Results
The automated methods for image processing were first
tested on synthetic images computationally simulating
the biomarker decorated images of the tumoroid cross
sections (Figure 2). The accuracy of tissue segmentation
was 95.82% and 98.31% on average over synthetic images
mimicking Ecad and PR stained tissue cross section
images respectively (Tables 1 and 2). Morphological pro-
filing of DNA spots in terms of cross sectional area, eccen-
tricity, and mean inter-spot distances over synthesized
tumoroid cross-section images adequately captured the
true parameters of the DNA spots (Table 3). DNA spot
detection rates were over 93% both for Ecad-stained and
PR-stained synthetic cross-section images. The spots that
were missed were less than 5 µm2 in cross sectional area.
The average absolute errors in positively stained region
areas were less than 6% of the average area of synthesized
cross section images. The average error in DNA spot areas
in the PR-stained images was higher than that in Ecad-
stained images, possibly due to a two-class representation
of DNA-rich pixels in PR-stained images. Conversely, the
error in identifying the staining of the DNA spots was
E = −1 β
α
Table 1: Normalized confusion matrix of automated image segmentation on the synthesized Ecad-stained cross section images. The 
overall prediction accuracy measured by the sum of diagonal elements was 0.9582.
True class Predicted class
E1 E2 E3 E4 E5 total
E1 0.3457 0.0039 0.0000 0.0001 0.0000 0.3498
E2 0.0014 0.2832 0.0007 0.0062 0.0004 0.2919
E3 0.0000 0.0008 0.0426 0.0008 0.0000 0.0441
E4 0.0000 0.0000 0.0009 0.2270 0.0122 0.2400
E5 0.0001 0.0024 0.0001 0.0120 0.0596 0.0742
Total 0.3472 0.2902 0.0443 0.2461 0.0722 1.0000Page 6 of 14
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images, as the PR stain directly targets the DNA-rich image
content. The errors in spot eccentricities and inter-spot
distances were comparable between the synthetic images
representing Ecad and PR-stained tumoroid cross section
images.
Visual inspection of histology images of tumoroid sec-
tions decorated for Ecad or PR indicated that in many
instances these cross sections cut across cells of highly
invasive and poorly invasive phenotypes (Figures 3 and
4). The tumoroid shown in the figures is in the form of a
cell-rich shell encompassing a largely cell free core. As the
tumoroid grew with increasing durations of incubation,
Sample synthetic images used to validate the computational image analysis algorithms used in the manuscriptFigur  2
Sample synthetic images used to validate the computational image analysis algorithms used in the manuscript. First, a three-
dimensional tissue block was generated randomly within a 128 µm × 128 µm × 64 m volume. Random tissue maps were 
obtained as 9 horizontal cross sections of this tissue block at 4 µm intervals near the vertical center, where the membranes, 
cytoplasms, and the nuclei of Ecad+/PR+ and Ecad-/PR- cells were marked with different labels. The associated Ecad-stained 
and PR-stained cross section images were generated by assigning colors from among those observed in the reference tumoroid 
cross section images followed by smoothing (bottom row). Overall, 5 such tissue blocks were generated, producing a total of 
45 random tissue maps and respectively stained synthetic images. Image acquisition was modeled at 40×.Page 7 of 14
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quently, possibly as a result of insufficient diffusion of
nutrients and oxygen across the thickness of the tumor-
oid. The tumoroid shells in these images ranged in thick-
ness from 100–140 µm. The presence of small cell clusters
of different phenotypes on the same cross section side by
side can be observed clearly in Figures 3 and 4, indicating
that cells belonging to different phenotypes are able to
adhere to each other even in the absence of E-cadherin
(homotypic cell-cell adhesion molecules). Similarly, the
visual inspection of the same figure shows that PR stain-
ing is also efficient in identifying the microscopic bound-
aries of cell clusters belonging to different phenotypes.
The automated segmentation procedure described in the
methods section separates image regions occupied by
highly invasive cells (blue) from those regions occupied
by poorly invasive cells at a coarser scale. The visual com-
parison of top and bottom rows of Figures 3 and 4 indi-
cate that automated segmentation correctly captures the
presence of different cell phenotypes in a histology slide
image globally, without the need for visualization at the
physical dimensions of a living cell.
The automated image analysis showed that composite
tumoroids that were developed using poorly invasive to
highly invasive cells at a three-to-one ratio contained
largely cells of poorly invasive phenotype (Figure 5). On
the average, invasive cell phenotype occupied 34 % of the
tumoroid cross section in images stained for Ecad and
39% of the cross section in images stained for PR. The
composition of a tumoroid cross section varied from cross
section to cross section for tumoroids developed under
identical co-culture conditions as shown in Figure 5. Adja-
cent cross sections of the same tumoroid stained for PR
and stained for Ecad, however, showed closer prediction
of the highly invasive cell phenotype regions. These
results indicate the cell phenotype composition of a com-
posite tumoroid cannot be estimated accurately by com-
puting the corresponding composition in the images of a
few tumoroid cross sections. On the other hand, auto-
mated segmentation developed in this study allows for
the creation of tissue arrays from composite tumoroid
cross sections for high throughput studies on potential
drugs.
Discussion
As modern pathology explores the use of automated
image processing systems for accurate diagnosis of cancer
class, similar automated techniques are needed to analyze
images of tissue microarrays containing images from hun-
dreds of different tissues in a single array. Tissue arrays
that correspond to adjacent slides of a composite block
are stained for different biomarkers [56-59] and therefore
it is necessary to identify the image regions that belong to
cells expressing a particular biomarker. The computa-
tional image analysis algorithms used in this manuscript
were validated over synthesized Ecad and PR stained cross
section images. The results shown in Tables 1, 2, and 3
indicated high accuracy in tissue segmentation as well as
molecular and morphological profiling of DNA spots in
Table 3: Error statistics of the image analysis methods used for determining the staining patterns and detecting DNA spots on the 
synthesized cross section images. The statistics were averaged over 45 randomly generated cross section images.
Ecad-stained images PR-stained images
True DNA spot detection rate 93.77% 93.07%
False DNA spot detection rate 0.00% 0.00%
Absolute error in positively stained area (µm2) 615.2412 537.0872
Absolute error in DNA spot area (A) (µm2) 0.4031 1.1964
Absolute error in DNA spot eccentricity (E) 0.0270 0.0244
Absolute error in inter-spot distances (D) (µm) 1.0314 1.1536
Error rate of staining prediction 8.38% 6.56%
Table 2: Normalized confusion matrix of automated image segmentation on the synthesized PR-stained cross section images. The 
overall prediction accuracy measured by the sum of diagonal elements was 0.9831.
True class Predicted class
P1 P2 P3 P4 P5 total
P1 0.3460 0.0038 0.0000 0.0000 0.0000 0.3498
P2 0.0013 0.2886 0.0016 0.0003 0.0000 0.2919
P3 0.0003 0.0066 0.3068 0.0000 0.0005 0.3142
P4 0.0000 0.0012 0.0000 0.0200 0.0000 0.0212
P5 0.0000 0.0000 0.0012 0.0000 0.0217 0.0230
Total 0.3476 0.3002 0.3096 0.0203 0.0222 1.0000Page 8 of 14
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Processing of membrane-targeting Ecad stained tumoroid cross section imagesFigure 3
Processing of membrane-targeting Ecad stained tumoroid cross section images. The original image at 40× (top), the segmenta-
tion (middle), and the deduced staining patterns are shown (left column) along with marked high magnification boxes of width 
156 µm (right column).
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Processing of nuclei-targeting PR stained tumoroid cross section imagesFigure 4
Processing of nuclei-targeting PR stained tumoroid cross section images. The original image at 40× (top), the segmentation 
(middle), and the deduced staining patterns are shown (left column) along with marked high magnification boxes of width 156 
µm (right column).
BMC Medical Imaging 2007, 7:7 http://www.biomedcentral.com/1471-2342/7/7synthetic images. In comparison, measurements of DNA
spot areas were more accurate in Ecad-stained cross sec-
tion images, while DNA spot staining was determined
more accurately in PR-stained cross section images. Over-
all, the performances of the image analysis methods were
comparable on synthesized image data for both stains.
While the synthesized cross-section images provide a sim-
plified view of real histology imagery in terms of geometry
and optical characteristics, these results illustrate the oper-
ating characteristics of the image processing algorithms in
assessing the expressions of membrane- and nuclei-
bound biomarkers.
Since the image analysis methods presented in this paper
operate on a pixel-based approach in identifying the stain-
ing of cell nucleus or membrane, they can be easily gener-
alized to analyze sub-cellular staining characteristics of
tumoroid cross-section images as well. Estimation of cell
boundaries would be required to assess cytoplasmic stain-
ing on a per cell basis [60]. In such instances, the image
resolution stands the critical issue in recognizing posi-
tively stained pixels, since small pixel clusters may be lost
through the course of mathematical morphological oper-
ations. Image resolution also underlines the distinction of
the pixel-based strategy presented here from an object-
based approach aimed at recognizing cellular structures in
cross-section images first and then examining their stain-
ing properties [38]. Object recognition is inherently based
on geometric detail, and requires resolution levels much
finer than the typical size of the objects of interest. On the
other hand, object-based strategies can achieve greater
robustness to variations in tissue preparation and imaging
conditions by invoking the geometric information in the
process through model-based segmentation, such as
resolving instances of partial staining and overlapping
nuclei [61].
The present image processing study involving in vitro
tumoroid cross sections showed that these tumoroids cap-
ture the heterogeneous composition of human breast
tumors. Moreover, our automated image analysis is capa-
ble of identifying image regions correspond to cells
expression different biomarkers. The two biomarkers that
we tested our image analysis rest in different regions of a
breast cell: Ecad is located on cell boundaries whereas PR
is a protein that is located in the nucleus as well as in the
cell cytoplasm. Stains for these biomarkers often diffused
around the biomarker in the tumoroid slides. Our image
segmentation took stain diffusion into consideration via
separate pixel classes representing cytoplasmic expression
Aerial and DNA spot percentages of positively and negatively stained regionsFigure 5
Aerial and DNA spot percentages of positively and negatively stained regions. The percentages based on areas and the number 
of DNA spots in positively and negatively stained regions were very similar between different cross sections of tumoroids. The 
positive staining percentages of PR and Ecad staining followed each other in general to within a difference of 12% even though 
differences as large as 30% were also observed. In the charts above, positive staining is shown in red and negative staining is 
shown in blue.Page 11 of 14
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of interest even in the presence of significant biomarker
diffusion.
Conclusion
This article presents an automated analysis of breast
tumoroid cross sections that are stained for cell nuclei and
further decorated with nuclear and membrane bound
biomarkers. Specifically we have developed imaging tools
that differentiate various cell types in the image based on
cell membrane bound and nuclear bound protein mark-
ers. Our automated image processing codes take into
account the inadvertent diffusion of stains that occurs in
many histology slides and differentiates different cell phe-
notypes on the image, allowing scientists to determine
computationally the biological region of interest. The syn-
thetic images generated in this article could be used as
standard images in assessing the effectiveness of histopa-
thology image segmentation tools in differentiatiating
between cell phenotypes. The need for automated image
analysis and classification of tumoroid histology will
increase with further incorporation quantum dots [62,63]
and other nanosystems into tissue microarray technology
for keeping track of multiple biomarkers on the images of
the same histology slide. The accuracy at which three-
dimensional cell cultures emulate actual tumor tissue and
in vivo tissue microenvironment can be improved further
by co-culturing not only different cell lines but also cells
of stromal origin [12]. Coupled with the automated image
analysis methods as presented here for rapid profiling of
the molecular anatomy of the resulting tumoroids, this
offers a great potential for standardized high throughput
evaluation of prospective drugs for anti-cancer perform-
ance.
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